Table of Contents
Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis & Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Cancer Diagnostics Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.2.1 Rising prevalence of cancer cases
3.2.2 Technological advancement
3.2.3 Initiatives undertaken by government
3.2.4 Reimbursement coverage
3.3 Market Restraints Analysis
3.3.1 Lack of sensitivity and specificity
3.3.2 Risk of high radiation exposure used in different treatments
3.3.3 Cost of diagnosis
3.4 Penetration & growth prospect mapping
3.5 Cancer Diagnostics – SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis – Porter’s
Chapter 4 Cancer Diagnostics: Screening Type Estimates & Trend Analysis
4.1 Cancer Diagnostics Market: Screening Type movement analysis
4.1.1. Laboratory Tests
4.1.1.1 Laboratory Tests Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
4.1.2 Genetic Tests
4.1.2.1 Genetic Tests Market Estimates and Forecasts, 2014 – 2025 (USD Billion))
4.1.3 Imaging
4.1.3.1 Imaging Market Estimates and Forecasts, 2014 – 2025 (USD Billion))
4.1.4 Endoscopy
4.1.4.1 Endoscopy Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
4.1.5 Biopsy
4.1.5.1 Biopsy Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
4.1.6 Others ( Barium Enema)
4.1.6.1 Others Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
Chapter 5 Cancer Diagnostics: Application Estimates & Trend Analysis
5.1 Cancer Diagnostics Market: Application movement analysis
5.1.1 Breast Cancer
5.1.1.1 Breast Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.2 Colorectal Cancer
5.1.2.1 Colorectal Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.3 Cervical Cancer
5.1.3.1 Cervical Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.4 Lung Cancer
5.1.4.1 Lung Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.5 Prostate cancer
5.1.5.1 Prostate Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.6 Skin Cancer
5.1.6.1 Skin Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.7 Blood Cancer
5.1.7.1 Blood Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.8 Kidney Cancer
5.1.8.1 Kidney Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.9 Liver Cancer
5.1.9.1 Liver Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.10 Pancreatic Cancer
5.1.10.1 Pancreatic Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.11 Ovarian Cancer
5.1.11.1 Ovarian Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.12 Others
5.1.12.1 Others Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
Chapter 6 Cancer Diagnostics: Regional Estimates &Trend Analysis, by Screening Type & Application Type
6.1 Cancer Diagnostics Market Share By Region, 2015 & 2025
6.2 North America
6.2.1 North America Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.2.2 U.S.
6.2.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.2.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.2.3 Canada
6.2.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.2.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.3 Europe
6.3.1 Europe Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.3.2 UK
6.3.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.3.3 Germany
6.3.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.4.2 Japan
6.3.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.4.3 China
6.3.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.5.2 Brazil
6.5.2.1 Market Estimates & forecast, By Screening Type 2014 – 2025 (USD Billion)
6.5.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.5.3 Mexico
6.5.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.5.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.6 MEA
6.6.1 MEA Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.6.2 South Africa
6.6.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.6.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Abbott
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Qiagen
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Siemens Healthcare GmbH
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 GE Healthcare
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Hologic,Inc.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Koninklijke Philips N.V.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Illumina, Inc.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Penetration & Growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Cancer Diagnostics Market product outlook key takeaways
FIG. 16 Cancer Diagnostics: Screening Type movement analysis
FIG. 17 Laboratory Tests Market, 2014 - 2025 (USDBillion)
FIG. 18 Genetic Tests Market, 2014 - 2025 (USD Billion)
FIG. 19 Imaging Market, 2014 - 2025 (USD Billion)
FIG. 20 Endoscopy Market, 2014 - 2025 (USD Billion)
FIG. 21 BiopsyMarket, 2014 - 2025 (USD Billion
FIG. 22 Others Market, 2014 - 2025 (USDBillion)
FIG. 23 Cancer Diagnostics market Application outlook key takeaways
FIG. 24 Cancer Diagnostics : Application movement analysis
FIG. 25 Breast Cancer Market, 2014 - 2025 (USD Billion)
FIG. 26 Colorectal Cancer Market, 2014 - 2025 (USD Billion)
FIG. 27 Cervical Cancer Market, 2014 - 2025 (USD Billion)
FIG. 28 Lung Cancer Market, 2014 - 2025 (USD Billion)
FIG. 29 Prostate Cancer Market, 2014 - 2025 (USD Billion)
FIG. 30 Skin Cancer Market, 2014 - 2025 (USDBillion)
FIG. 31 Blood Cancer Market, 2014 - 2025 (USDBillion)
FIG. 32 Kidney Cancer Market, 2014 - 2025 (USD Billion)
FIG. 33 Liver Cancer Market, 2014 - 2025 (USD Billion)
FIG. 34 Pancreatic Cancer Market, 2014 - 2025 (USD Billion)
FIG. 35 Ovarian Cancer Market, 2014 - 2025 (USD Billion)
FIG. 36 Others Market, 2014 - 2025 (USD Billion)
FIG. 37 Regional market place: Key takeaways
FIG. 38 Strategy framework
FIG. 39 Participant categorization
List of Tables
TABLE 1 North America Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 2 North America Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 3 U.S. Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 4 U.S. Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 5 Canada Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 6 Canada Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 7 Europe Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 8 Europe Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 9 UK Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 10 UK Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 11 Germany Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 12 Germany Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 13 Asia Pacific Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 14 Asia Pacific Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 15 Japan Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USDBillion);
TABLE 16 Japan Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 17 China Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 18 China Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 19 Latin America Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 20 Latin America Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 21 Brazil Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USDBillion)
TABLE 22 Brazil Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 23 Mexico Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 24 Mexico Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 25 MEA Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 26 MEA Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 27 South Africa Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 28 South Africa Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
【免責事項】
http://www.globalresearch.jp/disclaimer